9:00 AM-9:45 AM
Opening
Opening Speech
Mario Brandenburg, Parliamentary State Secretary to the Federal Minister of Education and Research (BMBF)
Welcome
Prof. Christopher Baum, Chair of the BIH Board of Directors and Chief Translational Research Officer, Charité Berlin
Christian Tretbar, Editor-in-chief, Tagesspiegel
Introduction by Dr. Michael May, Medical Director Germany, Bristol Myers Squibb, on “Biopharmaceutical research and innovation – a key value driver for our society”
9:45 AM-10:00 AM
Impulse
Thomas Müller, Head of Department 1 “Drugs, Medical Devices, Biotechnology" - Federal Ministry of Health
10:00 AM-11:00 AM
Session 1
Societal and Medical Need: The role of cell- and nucleic acid-based therapies and digitization
In this session, 20 international and national speakers will present short, concise talks on how cell and gene therapy must develop in a societal context. The scientific findings will have their say, as will a patient representative or the issue of the cost of these novel therapies. The digitization of information pathways and the recording of clinical parameters that are also relevant for patients is a prerequisite for the successful implementation of new therapies and will also be addressed.
Chair: Prof. Simone Spuler, Experimental and Clinical Research Center (ECRC), Charité Berlin and MDC for Molecular Medicine
Short presentations
11:00 AM-11:30 AM
Coffee Break
with Meet the Speakers corner
11:30 AM-12:35 PM
Session 2
Future Work: The role of shared laboratories and incubators
In this session, the panel will discuss the role and impact of shared laboratories and incubators in establishing strong innovation ecosystems. In recent years, a better understanding of what constitutes an optimal environment for scientific innovators has emerged, especially to facilitate entrepreneurial translation in the medical and biotechnology fields. The best innovation communities provide not just a highly functional laboratory environment, but they also facilitate the creation of strong networks – as captured in the motto of “Reducing Friction & Increasing Collisions” that has been the guiding principle for the LabCentral/Biolabs ecosystems.
The members of the panel are scientists and practitioners of shared innovation and will discuss best practices and experiences – and how these can be applied to help Berlin build a world-class innovation ecosystem.
Panel discussion
Presenter: Johannes Fruehauf M.D. Ph.D., President & CEO, BioLabs and President & Executive Director, LabCentral
With Julia Schaft, Trine Bartholdy, Brigitte Drees
Part 2: Short presentations
12:35 PM-12:45 PM
Opinion poll results by Civey
Steffen Braun, Partner and VP Sales, Civey
12:45 PM-2:15 PM
Lunch Break
With Meet the Speakers corner
1:15 PM-2:00 PM
Side Event: Lunch talk about cancer cell therapies (German language)
Zelltherapien gegen Krebs: moderne Forschungsansätze und aktuell klinische Praxis in Deutschland (German language)
Prof. Lars Bullinger, Medical Director of the Department of Hematology, Oncology and Cancer Immunology CVK, Charité Berlin
Dr. Anne Kerber, Senior Vice President and Head of Cell Therapy Development, Bristol Myers Squibb
Please note: the event is already booked out. We will inform you on the day of the event if there are any slots left open.
2:30 PM-2:45 PM
Keynote Lecture
Boundary Conditions for Medical Innovation Start-Ups
Prof. Dietmar Harhoff, Director, Max Planck Institute for Innovation and Competition
2:45 PM-3:00 PM
Part 1: Stories from Real Life: How to succeed when building your start-up
Raising Funds: How to attract competitive translational research grants, private money or venture capital
Chair: Dr. Andreas Schmidt, Entrepreneur, former CEO Proteona - now Singleron
Part 1: Stories from Real Life: How to succeed when building your start-up
Ready for a roller coaster ride? Then start a deep tech company. Almost certainly business plans and technological solutions will change along the journey. It is up to a passionate entrepreneurial team to weather the uncertainties of navigating the terra incognita to revolutionary products, economic success and patient impact. In this session you will hear from a range of inspiring health entrepreneurs about their stories on crucial success factors - and failures they have overcome. Buckle up.
Short presentations
3:00 PM-3:30 PM
Part 2: Raising Funds
Session 3
Part 2: Raising Funds: How to attract competitive translational research grants, private money or venture capital
Panel discussion
Dr. Claudia Baumann, Policy Officer and Deputy Head of Division of New Methods in Life Sciences, Biotechnology, Drug Development (BMBF)
Dr. Regina Hodits, Managing Partner, Wellington Partners
Dr. Andreas Schmidt, Entrepreneur, former CEO Proteona – now SVP Singleron
Presenter: Katrin Neumann, freelance journalist and presenter
3:30 PM-4:00 PM
Coffee Break 2
With Meet the Speakers corner
4:00 PM-4:15 PM
Impulse (German language)
Ulrike Gote, Senator for Higher Education and Research, Health, Long-Term Care and Gender Equality, Berlin
Please note: this impulse will be held in German
4:15 PM-4:25 PM
Part 1: Tech Talk on Mindset and Education
Session 4
Mindset and Education: The new generation of innovators, entrepreneurial scientists and physicians
Entrepreneurship is more than just building startups. Entrepreneurship is the fuel that empowers future innovators and a new generation of science-backed innovations in healthcare. By understanding the entrepreneurial toolbox, scientists, physicians and innovators will be enabled to master the convergence of disciplines, co-create groundbreaking innovations and ultimately deliver valuable solutions. Let us get inspired by real-life examples of how to spark an entrepreneurial mindset and educate future entrepreneurial leaders.
Chair: Dr. Thorsten Lambertus, Director, DEEP - Institute for Deep Tech Innovation, ESMT Berlin
Part 1: Tech Talk on Mindset and Education
with Victoria Williams, SVP & General Manager, GSK Germany (10min)
Presenter: Dr. Thorsten Lambertus, Director, DEEP - Institute for Deep Tech Innovation, ESMT Berlin
4:25 PM-5:25 PM
Part 2: Mindset and Education
Session 4
The new generation of innovators, entrepreneurial scientists and physicians
Short presentations
5:25 PM-5:30 PM
Opinion poll results by Civey
Steffen Braun, Partner and VP Sales, Civey
5:30 PM-5:40 PM
Final Keynote
Prof. Dr. Axel R. Pries, Dean, Charité Berlin
5:40 PM-5:55 PM
Winner honouring
Dr. Joachim Haes, Director Government Affairs DACH, Intuitive Surgical Deutschland GmbH
5:55 PM-6:00 PM
Fare Well
Prof. Christopher Baum, Chair of the BIH Board of Directors and Chief Translational Research Officer, Charité Berlin
Christian Tretbar, Editor-in-chief, Tagesspiegel
6:00 PM-6:00 PM
Networking evening event
with Meet the Speakers corner
